These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 25932153)

  • 1. Chemopreventive effects of 5-amino salicylic acids on inflammatory bowel disease-associated colonic cancer and colonic dysplasia: a meta-analysis.
    Xu X; Xu X; Ciren Y; Feng B; Tao C; Xia Y; Liu Z
    Int J Clin Exp Med; 2015; 8(2):2212-8. PubMed ID: 25932153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemopreventive effects of 5-aminosalicylic acid on inflammatory bowel disease-associated colorectal cancer and dysplasia: a systematic review with meta-analysis.
    Qiu X; Ma J; Wang K; Zhang H
    Oncotarget; 2017 Jan; 8(1):1031-1045. PubMed ID: 27906680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
    Collins PD; Mpofu C; Watson AJ; Rhodes JM
    Cochrane Database Syst Rev; 2006 Apr; (2):CD000279. PubMed ID: 16625534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for detecting colon cancer and/or dysplasia in patients with inflammatory bowel disease.
    Mpofu C; Watson AJ; Rhodes JM
    Cochrane Database Syst Rev; 2004; (2):CD000279. PubMed ID: 15106148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial Dysplasia and Cancer in IBD Strictures.
    Sonnenberg A; Genta RM
    J Crohns Colitis; 2015 Sep; 9(9):769-75. PubMed ID: 26079724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between CD24 gene polymorphisms and inflammatory bowel disease: A meta-analysis.
    Huang XL; Xu DH; Wang GP; Zhang S; Yu CG
    World J Gastroenterol; 2015 May; 21(19):6052-9. PubMed ID: 26019472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic problems and advances in inflammatory bowel disease.
    Odze R
    Mod Pathol; 2003 Apr; 16(4):347-58. PubMed ID: 12692200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oral vs. topical, or combined oral and topical 5-aminosalicylates, in Ulcerative Colitis: systematic review and meta-analysis.
    Ford AC; Khan KJ; Achkar JP; Moayyedi P
    Am J Gastroenterol; 2012 Feb; 107(2):167-76; author reply 177. PubMed ID: 22108446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Dysplasia or Cancer in 3.5% of Patients With Inflammatory Bowel Disease and Colonic Strictures.
    Fumery M; Pineton de Chambrun G; Stefanescu C; Buisson A; Bressenot A; Beaugerie L; Amiot A; Altwegg R; Savoye G; Abitbol V; Bouguen G; Simon M; Duffas JP; Hébuterne X; Nancey S; Roblin X; Leteurtre E; Bommelaer G; Lefevre JH; Brunetti F; Guillon F; Bouhnik Y; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1770-5. PubMed ID: 26001338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.
    Cheng Y; Desreumaux P
    World J Gastroenterol; 2005 Jan; 11(3):309-14. PubMed ID: 15637733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
    Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
    J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Meta-analysis on causes of ulcerative colitis].
    Luo R; Huo L; Zhang J; Zhang Q
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Dec; 36(12):1419-23. PubMed ID: 26850404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
    J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis.
    Ungaro R; Bernstein CN; Gearry R; Hviid A; Kolho KL; Kronman MP; Shaw S; Van Kruiningen H; Colombel JF; Atreja A
    Am J Gastroenterol; 2014 Nov; 109(11):1728-38. PubMed ID: 25223575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease is associated with an increased risk of melanoma: a systematic review and meta-analysis.
    Singh S; Nagpal SJ; Murad MH; Yadav S; Kane SV; Pardi DS; Talwalkar JA; Loftus EV
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):210-8. PubMed ID: 23644389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease.
    Derwa Y; Gracie DJ; Hamlin PJ; Ford AC
    Aliment Pharmacol Ther; 2017 Aug; 46(4):389-400. PubMed ID: 28653751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis.
    Jess T; Lopez A; Andersson M; Beaugerie L; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1793-1800.e1. PubMed ID: 24907505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis.
    Chande N; McDonald JW; Macdonald JK
    Cochrane Database Syst Rev; 2008 Apr; (2):CD006774. PubMed ID: 18425969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk for colorectal neoplasia in patients with colonic Crohn's disease and concomitant primary sclerosing cholangitis.
    Braden B; Halliday J; Aryasingha S; Sharifi Y; Checchin D; Warren BF; Kitiyakara T; Travis SP; Chapman RW
    Clin Gastroenterol Hepatol; 2012 Mar; 10(3):303-8. PubMed ID: 22037429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.